SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response
Yuki Takamatsu(National Center for Global Health and Medicine), Hiroaki Mitsuya(National Institutes of Health)
Cited by 5
Related Papers
Enzymatic Characterization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistant to Multiple 2′,3′-Dideoxynucleoside 5′-Triphosphates
|Journal of Biological Chemistry|1995|101
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
|Research Square|2022|41